A screening method for identifying disruptions in interferon signaling reveals HCV NS3/4a disrupts Stat-1 phosphorylation

Antiviral Research

Volumn 77, Issue 3, 2008, Pages 169-176

  Helbig, Karla J ^a,b   Yip, Evelyn ^a,b   McCartney, Erin M ^b   Eyre, Nicholas S ^a,b   Beard, Michael R ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Hepatitis C virus; Interferon; Jak Stat

Indexed keywords

INTERFERON; JANUS KINASE; SERINE PROTEINASE; STAT1 PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL ASSAY; CELL SURVIVAL; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCREENING;

CARRIER PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; HEPACIVIRUS; HUMANS; INTERFERONS; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS; VIROLOGY;

HEPATITIS C VIRUS;

EID: 38749144367     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.11.008     Document Type: Article

References (36)

1. Ackrill A.M., Reid L.E., Gilbert C.S., Gewert D.R., Porter A.C., Lewin A.R., Stark G.R., and Kerr I.M. Differential response of the human 6-16 and 9-27 genes to alpha and gamma interferons. Nucleic Acids Res. 19 3 (1991) 591-598
2. Barnard P., and McMillan N.A. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology 259 2 (1999) 305-313
3. Barnard P., Payne E., and McMillan N.A. The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-alpha. Virology 277 2 (2000) 411-419
4. Best S.M., Morris K.L., Shannon J.G., Robertson S.J., Mitzel D.N., Park G.S., Boer E., Wolfinbarger J.B., and Bloom M.E. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J. Virol. 79 20 (2005) 12828-12839
5. Bode J.G., Ludwig S., Ehrhardt C., Albrecht U., Erhardt A., Schaper F., Heinrich P.C., and Haussinger D. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J. 17 3 (2003) 488-490
6. Chernajovsky Y., and Kirby-Sanders H.M. A cis-acting sequence, located at -450 in the promoter of the human interferon-inducible gene 6-16, binds constitutively to a nuclear protein and decreases the expression of a reporter interferon-inducible promoter. Lymphokine Res. 9 2 (1990) 199-212
7. Clarke D.T., Irving A.T., Lambley E.H., Payne E., and McMillan N.A. A novel method for screening viral interferon-resistance genes. J. Interferon Cytokine Res. 24 8 (2004) 470-477
8. Constantinescu S.N., Croze E., Wang C., Murti A., Basu L., Mullersman J.E., and Pfeffer L.M. Role of interferon alpha/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha/beta receptor complex. Proc. Natl. Acad. Sci. U.S.A. 91 20 (1994) 9602-9606
9. Dale T.C., Rosen J.M., Guille M.J., Lewin A.R., Porter A.G., Kerr I.M., and Stark G.R. Overlapping sites for constitutive and induced DNA binding factors involved in interferon-stimulated transcription. EMBO J. 8 3 (1989) 831-839
10. Der S.D., Zhou A., Williams B.R., and Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 95 26 (1998) 15623-15628
11. Foy E., Li K., Wang C., Sumpter Jr. R., Ikeda M., Lemon S.M., and Gale Jr. M. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300 5622 (2003) 1145-1148
12. Fu X.Y., Schindler C., Improta T., Aebersold R., and Darnell Jr. J.E. The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc. Natl. Acad. Sci. U.S.A. 89 16 (1992) 7840-7843
13. Gedey R., Jin X.L., Hinthong O., and Shisler J.L. Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells. J. Virol. 80 17 (2006) 8676-8685
14. Goh K.C., Haque S.J., and Williams B.R. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J. 18 20 (1999) 5601-5608
15. Grandvaux N., Servant M.J., tenOever B., Sen G.C., Balachandran S., Barber G.N., Lin R., and Hiscott J. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76 11 (2002) 5532-5539
16. Heim M.H., Moradpour D., and Blum H.E. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J. Virol. 73 10 (1999) 8469-8475
17. Helbig K.J., Lau D.T., Semendric L., Harley H.A., and Beard M.R. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42 3 (2005) 702-710
18. Kalvakolanu D.V., Bandyopadhyay S.K., Harter M.L., and Sen G.C. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc. Natl. Acad. Sci. U.S.A. 88 17 (1991) 7459-7463
19. Katze M.G., He Y., and Gale Jr. M. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2 9 (2002) 675-687
20. Kelly J.M., Gilbert C.S., Stark G.R., and Kerr I.M. Differential regulation of interferon-induced mRNAs and c-myc mRNA by alpha- and gamma-interferons. Eur. J. Biochem. 153 2 (1985) 367-371
21. Levy D.E., Kessler D.S., Pine R., and Darnell Jr. J.E. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev. 3 9 (1989) 1362-1371
22. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C., Ikeda M., Ray S.C., Gale Jr. M., and Lemon S.M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. U.S.A. 102 8 (2005) 2992-2997
23. Li X., Leung S., Qureshi S., Darnell Jr. J.E., and Stark G.R. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J. Biol. Chem. 271 10 (1996) 5790-5794
24. Lin R.J., Chang B.L., Yu H.P., Liao C.L., and Lin Y.L. Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J. Virol. 80 12 (2006) 5908-5918
25. Lin R.J., Liao C.L., Lin E., and Lin Y.L. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J. Virol. 78 17 (2004) 9285-9294
26. Lin W., Choe W.H., Hiasa Y., Kamegaya Y., Blackard J.T., Schmidt E.V., and Chung R.T. Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology 128 4 (2005) 1034-1041
27. Lin W., Kim S.S., Yeung E., Kamegaya Y., Blackard J.T., Kim K.A., Holtzman M.J., and Chung R.T. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J. Virol. 80 18 (2006) 9226-9235
28. Liu W.J., Wang X.J., Mokhonov V.V., Shi P.Y., Randall R., and Khromykh A.A. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J. Virol. 79 3 (2005) 1934-1942
29. Lyman M.G., Randall J.A., Calton C.M., and Banfield B.W. Localization of ERK/MAP kinase is regulated by the alphaherpesvirus tegument protein Us2. J. Virol. 80 14 (2006) 7159-7168
30. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., and Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 7062 (2005) 1167-1172
31. Pellegrini S., John J., Shearer M., Kerr I.M., and Stark G.R. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell Biol. (1989) 4605-4612
32. Pellegrini S., John J., Shearer M., Kerr I.M., and Stark G.R. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell Biol. 9 11 (1989) 4605-4612
33. Pilz A., Ramsauer K., Heidari H., Leitges M., Kovarik P., and Decker T. Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons. EMBO Rep. 4 4 (2003) 368-373
34. Schindler C., Fu X.Y., Improta T., Aebersold R., and Darnell Jr. J.E. Proteins of transcription factor ISGF-3: one gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc. Natl. Acad. Sci. U.S.A. 89 16 (1992) 7836-7839
35. Yan H., Krishnan K., Greenlund A.C., Gupta S., Lim J.T., Schreiber R.D., Schindler C.W., and Krolewski J.J. Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein. EMBO J. 15 5 (1996) 1064-1074
36. Zhang Y., Cho Y.Y., Petersen B.L., Zhu F., and Dong Z. Evidence of STAT1 phosphorylation modulated by MAPKs, MEK1 and MSK1. Carcinogenesis 25 7 (2004) 1165-1175